HFpEF in the Eyes of the European and U.S. Guidelines

[Speaker] Stuart Prenner / Univ. of Pennsylvania, USA

Therapies for HFpEF: The Impact of SGLT2 Inhibitors and ARNI’s on the Disease Process

[Speaker] Jaewon Oh / Yonsei Univ., Korea

Non-Pharmacological Approaches to Improving Symptoms and Exercise Capacity

[Speaker] Jagmeet Singh / Harvard Medical School, USA